Abstract
Objectives
Metoprolol is a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties, devoid of intrinsic sympathomimetic activity. Various studies have suggested the effect of beta-blockers on bone remodeling. We aimed to investigate whether metoprolol affects bone remodeling by altering anti-inflammatory and pro-inflammatory cytokines.
Materials and methods
Surgical defects of 3 mm diameter were created in tibiae of 72 Sprague-Dawley rats. Rats were randomly assigned to a control group without metoprolol treatment (n = 36), and a test group treated with 0.1 mg/kg/day metoprolol (n = 36). Six rats from each group were sacrificed at days 0, 1, 3, 5, 7, and 14. The percentages of cells, which showed positive immunohistochemical staining for IL-1β, IL-6, IL-10, and RANKL, were assessed in the defect area. Differences in percentages of stained cells within each of the test and control groups over various time intervals were tested using one-way ANOVA test. A P value of < 0.05 was considered statistically significant.
Results
No significant differences in IL-1β, IL-10, IL-6, and RANKL expressions were found between test and control groups at the same interval. Significant reduction was observed at different time intervals in the same group (P < 0.05).
Conclusion
Metoprolol did not reduce bone-active cytokine: IL-1β, IL-6, and RANKL. It also did not elevate IL-10 expression levels. Thus, it does not appear to decrease osteoclastogenesis.
Clinical relevance
Results from this animal model help us understand any effect of metoprolol on bone healing by potential contribution to different real-world clinical research.
Similar content being viewed by others
References
Gerstenfeld L, Cullinane D, Barnes G, Graves D, Einhorn T (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873–884
Einhorn T, Majeska RJ, Rush E, Levine P, Horowitz M (1995) The expression of cytokine activity by fracture callus. J Bone Miner Res 10(8):1272–1281
Harada SI, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423(6937):349
Hernández-Cortés P, Monje A, Galindo-Moreno P, Catena A, Ortega-Oller I, Salas-Pérez J, Mesa F, Gómez-Sánchez R, Aguilar M, Aguilar D, O’Valle F (2014) An ex vivo model in human femoral heads for histopathological study and resonance frequency analysis of dental implant primary stability. BioMed Res Int 2014
Tarantino U, Cerocchi I, Celi M, Scialdoni A, Saturnino L, Gasbarra E (2009) Pharmacological agents and bone healing. Clin Cases Miner Bone Metab 6(2):144
Bukata S (2011) Systemic administration of pharmacological agents and bone repair: what can we expect. Injury. 42(6):605–608
Frishman WH, Saunders E (2011) β-Adrenergic blockers. J Clin Hypertens 13(9):649–653
Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, et al. (2007). Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, Benhamou CL. Protective effect of β blockers in post- menopausal women: influence on fractures, bone density, micro and macroarchitecture. p 1209–1216
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker K et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell. 111(2):305–317
Bonnet N, Benhamou C, Malaval L, Goncalves C, Vico L, Eder V et al (2008) Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol 217(3):819–827 cellular physiology. 2008 Dec;217(3):819–27
Sadr K, Aghbali A, Sadr M, Abachizadeh H, Azizi M, Abbasi M (2017) Effect of Beta-blockers on number of osteoblasts and osteoclasts in alveolar socket following tooth extraction in Wistar rats. J Dent 18(1):37
Bologna-Molina R, Damián-Matsumura P (2011) An easy cell counting method for immunohistochemistry that does not use an image analysis program. Histopathology. 217(3):801–803
O’loughlin P, Morr S, Bogunovic L, Kim AD, Park B, Lane JM (2008) Selection and development of preclinical models in fracture-healing research. JBJS 90:79–84 JBJS. 2008 Feb 1;90:79–84
Guehennec LL, Goyenvalle E, Aguado E, Houchmand-Cuny M, Enkel B, Pilet P et al (2005) Small-animal models for testing macroporous ceramic bone substitutes. J Biomed Mater Res B Appl Biomater Offi J Soc Biomater Jpn Soc Biomater Aust Soc Biomater Korean Soc Biomater 72(1):69–78
Schmitz J, Hollinger J (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 205:205–299
Rodrigues W, Madeira M, Silva TD, Clemente-Napimoga J, Miguel CB, da Silva VJD et al (2012) Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br J Pharmacol 165(7):165–167
Group BDW, Jr AA, Colburn WA, DeGruttola VG, DeMets DL, Downing G et al (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95
Han D, Han N, Xue F, Zhang P (2015) A novel specialized staging system for cancellous fracture healing, distinct from traditional healing pattern of diaphysis cortical fracture. Int J Clin Exp Med 8(1):1301
Inoue S, Otsuka H, Takito J, Nakamura M (2018) Decisive differences in the bone repair processes of the metaphysis and diaphysis in young mice. Bone Reports 8:1–8
Iizuka T, Miller SC, Jr SM (1992) Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats. J Oral Pathol Med 21(4):150–155
Devlin H, Hoyland J, Newall JF, Ayad S (1997) Trabecular bone forma- tion in the healing of the rodent molar tooth extraction socket. J Bone Miner Res 12(12):2061–2067 12(12):2061–7
Vieira A, Repeke CE, Junior SD, Colavite PM, Biguestti CC, Oliveria R et al (2015) Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization. PLoS One 10(5):e0128021
Sabatini M, Aufdemorte T, Bonewald L, Mundy G (1988) Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci 85(14):5235–5239
Roodman G (1992) Perspectives: interleukin-6: an osteotropic factor? J Bone Miner Res 7(5):475–478
Konda A, Mogi M, Koshihara Y, Togari A (2001) Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochemical pharmacology. Biochem Pharmacol 61(3):319–326
Tera T, Prado RF, de Marco A, Santamaria MP, Jardini MA (2014) The RANK/RANKL/OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. Braz Oral Res 28(1):1–9
Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Bréart G (2005) Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l’Osteoporose prospective study. J Am Geriatr Soc 53(3):550–552
Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC (2005) β-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20(4):613–618
Khosla S, Volkman TL, Thicke BS, Achenbach SJ, Atkinson EJ, Joyner MJ, et al. (2018). Sympathetic β 1-adrenergic signaling contributes to regulation of human bone metabolism. J Clin 128(11)
Zang Y, Tan Q, Ma X, Zhao X, Lei W (2016) Osteogenic actions of metoprolol in an ovariectomized rat model of menopause. Menopause. 23(9):1019–1025
Acknowledgements
The authors would like to acknowledge Rayan Arfawi, Anas Aldowaji, Tayeb Kanaan, and Bashar Obeid for their assistance in this study.
Funding
This study was fully funded by the Deanship of Scientific Research, Jordan University of Science and Technology (JUST). Number 20170375
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
The study was independently reviewed and approved by the Institutional Research Board (IRB) of Jordan University of Science and Technology (JUST).
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al Alawy, R., Hammad, H. & AlHabashneh, R. The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study. Clin Oral Invest 24, 1239–1247 (2020). https://doi.org/10.1007/s00784-019-02987-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-019-02987-w